Efficacy and safety of Janus kinase inhibitors in systemic and cutaneous lupus erythematosus: A systematic review and meta-analysis.
Ma L, Peng L, Zhao J, Bai W, Jiang N, Zhang S, Wu C, Wang L, Xu D, Leng X, Wang Q, Zhang W, Zhao Y, Tian X, Li M, Zeng X.
Ma L, et al. Among authors: xu d.
Autoimmun Rev. 2023 Dec;22(12):103440. doi: 10.1016/j.autrev.2023.103440. Epub 2023 Sep 9.
Autoimmun Rev. 2023.
PMID: 37678618
Review.